News | July 06, 2022
Vaccizone selects Exothera for GMP manufacturing of its SARS?CoV?2 vaccine
Vaccizone’s ASC Technology is an enhanced antigen/bioactive delivery method based on Antigen Presenting Cells
Vaccizone’s ASC Technology is an enhanced antigen/bioactive delivery method based on Antigen Presenting Cells
Transcatheter Mitral valve procedure allows intervention on patients who are unsuitable or high risk for open heart surgery
Medicines, including insulin, to be available in 40 lower-income countries
Younger Indians have a 10 times higher rate of heart attack
People in India are still wary of organ transplants. So, there is an urgent need of increased public awareness.
Sanofi will begin to ship their vaccines helping to ensure more people will be immunized
Submission seeks approval for the treatment of COVID-19 in both vaccinated and unvaccinated individuals at high risk
Pfizer aims to achieve net-zero targets ten years earlier than the expectations of the Net-Zero Standard
Govt committed to supporting pharma companies with industry-friendly policies
The investment will enable the company to provide customers with a complete and integrated end-to-end solution
Subscribe To Our Newsletter & Stay Updated
